Vero
U.S. ICD-10-CM · FY 2027

T38.3X5D ICD-10-CM Code: Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter

A clear reference for the official code description, hierarchy, and related coding information from the FY 2027 U.S. release.

Code definition

Official description

T38.3X5D

Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter

ICD-10-CM diagnosis code · United States clinical modification

Classification

Where T38.3X5D sits

  1. 1

    Chapter 19

    Injury, poisoning and certain other consequences of external causes (S00-T88)

  2. 2

    Section

    Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)

  3. 3

    Category T38

    Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified

  4. 4

    Subcategory T38.3X5

    Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs

  5. 5

    Code T38.3X5D

    Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter

Documentation details

Notes for this code

Inclusion terms

No inclusion terms are listed for T38.3X5D.

Code first

No “code first” instruction is listed for T38.3X5D.

Use additional code

No “use additional code” instruction is listed for T38.3X5D.

Excludes1

Conditions that should not be reported together with this code.

No Excludes1 note is listed for T38.3X5D.

Excludes2

Conditions not included here that may be reported separately when present.

No Excludes2 note is listed for T38.3X5D.

Transparency

Source and release

Data release

U.S. ICD-10-CM · FY 2027

Effective date

Oct 1, 2026

This reference is generated from Vero’s ICD-10-CM description, hierarchy, and code-note dataset. The visible content and structured data share that source.

Review the CDC/NCHS ICD-10-CM source

Code-specific guidance

Frequently asked questions

What does ICD-10-CM code T38.3X5D mean?

T38.3X5D is the FY 2027 U.S. ICD-10-CM code for “Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs, subsequent encounter.”

Is T38.3X5D a billable or specific ICD-10-CM code?

Yes. In the FY 2027 reference data used on this page, T38.3X5D has no child codes and is presented as a billable/specific code. Always confirm the active code set and payer requirements before use.

Where is T38.3X5D located in ICD-10-CM?

T38.3X5D is listed in Chapter 19, Injury, poisoning and certain other consequences of external causes (S00-T88), within Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50) (T36–T50), under category T38, Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified and subcategory T38.3X5, Adverse effect of insulin and oral hypoglycemic [antidiabetic] drugs.

What coding notes are listed for T38.3X5D?

No inclusion terms are listed for T38.3X5D in this reference record. No code-first instruction is listed. No Excludes1 note is listed. No Excludes2 note is listed.

Keep exploring

Ready to transform your clinical documentation?

Join Vero and see how effortless documentation can be.

  • No credit card required

  • Cancel anytime